Original Research
Accepted on 19 May 2025
Evolution of ceftazidime-avibactam resistance driven by variation in bla KPC-2 to bla KPC-190 during treatment of ST11-K64 hypervirulent Klebsiella pneumoniae
in Antibiotic Resistance and New Antimicrobial drugs